Clinical Trials Directory

Trials / Unknown

UnknownNCT03552497

The Potential of Radiomics to Differentiate Between Malignant and Benign Bosniak 3 Renal Cysts.

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Maastricht University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

More than 200,000 new cases of renal cancer are diagnosed in the world each year, with more than 63,000 new cases in Europe alone. Of those, renal cell carcinoma (RCC) is the most common type in adults, making up more than 90% of the cases. Deciding on the benign or malignant nature of some RCC on the basis of medical images (CT, MRI, US) is an issue, which often leads to unnecessary surgery, morbidity and costs. A categorization for renal cysts was introduced in the late 1980s known as the Bosniak classification. The Bosniak classification system classifies them into groups that are benign (I and II) and those that need surgical resection (III and IV), based on specific imaging features. However, defining the malignancy of category III lesions still remains a challenge. Though Bosniak classification for renal cysts is used worldwide and underwent a number of modifications, Bosniak III cysts still have almost a 1:1 chance of being malignant. So the problem is that approximately half of the Bosniak category III cystic lesions prove to be benign after surgery. The proposed project aims to develop a quantitative image analysis (QIA) based multifactorial decision support system (mDSS) capable of classifying renal cysts with high accuracy into benign or malignant status, thus reducing the amount of unnecessary surgeries performed. Using standard-of-care CT images and clinical parameters, the customized DSS will then guide experts in planning a safe and effective diagnostic and treatment strategy for all RCC patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRadiomicsThe high-throughput extraction of large amounts of quantitative image features from radiographic medical images

Timeline

Start date
2018-08-07
Primary completion
2020-12-01
Completion
2021-01-31
First posted
2018-06-12
Last updated
2020-04-06

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03552497. Inclusion in this directory is not an endorsement.